A new clinical trial has recently been launched which assesses the use of autologous haematopoietic stem cells, like those found in umbilical cord blood, can be used to treat multiple sclerosis [MS]<\/p>\n
<\/p>\n
This latest trial aims to combine a haematopoietic stem cell transplant with dose immunosuppressive therapy [a class of drugs used to reduce the strength of the immune system] and decreased intensity beam conditioning chemotherapy [a high dose chemotherapy treatment].<\/p>\n
The study was performed on 99 patients that had been diagnosed with MS. The trial was used on two different types of MS; relapsing remitting MS, secondary progressive MS, primary progressive MS and progressive relapsing MS.<\/p>\n
The results of this clinical trial proved to be successful with 98% of the patients demonstrating neurological stability six months after the transplantation.<\/p>\n
These results show great potential and encouragement for the use of stem cells to help treat this condition.<\/p>\n
For more information on how to store your umbilical cord stem cells as well as other diseases that can presently be treated with UCB simply visit: Cord blood and cord tissue cell banking<\/u><\/a>.<\/p>\n